Definitive Contract 75N93018C00021
Award Date
7/31/18
Potential Completion Date
10/31/19
Potential Value
$225K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Hemex Health Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Portland, OR 97239, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
16
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This $221,889 firm fixed-price SBIR Phase I contract was awarded by the Department of Health and Human Services National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to HDT Bio Corp, a biopharmaceutical company, for "Diagnostics to Enable Malaria and Neglected Tropical Diseases". The contract originated from the NIH/Centers for Disease Control and Prevention (CDC) Small Business Innovation Research (SBIR) Program Solicitation PHS 2018-1, which sought...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $216,444 Small Business Innovation Research (SBIR) Phase I contract to Crosslife Technologies Inc., a self-certified small disadvantaged business, to conduct research and development on diagnostics to enable the detection and elimination of malaria and neglected tropical diseases. The contract was awarded under the NIH/CDC SBIR Contract Solicitation PHS...
This is a $299,986 firm fixed-price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Big Eye Diagnostics Inc., a small business manufacturer, for the development and validation of novel diagnostic biomarkers for malaria and select neglected tropical diseases. The contract is part of NIAID's Small Business Innovation Research (SBIR) program, which provides funding to small businesses for innovative research and development. The objective is to create rapid,...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $299,993 Small Business Innovation Research (SBIR) Phase I contract to Chromologic LLC, a minority-owned and Asian-Indian American-owned limited liability company, for the development of "Mobile Health Point-of-Care Diagnostics for Malaria." This contract is focused on research and development of rapid diagnostic technologies for malaria, a...
The U.S. Department of Health and Human Services, National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Definitive Contract in the amount of $299,974 to Crosslife Technologies Inc., a self-certified small disadvantaged business, for a Small Business Innovation Research (SBIR) Phase I project titled "A Rapid Nucleic Acid Test for the Point of Care Detection of Malaria." The contract was set aside for total small...
This is a $225,000.00 Small Business Innovation Research (SBIR) Program Phase I contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Nanocomposix, Inc., a manufacturer of engineered nanoparticles. The contract is for the development of "TOPIC 59 DIAGNOSTICS TO ENABLE MALARIA AND NEGLECTED TROPICAL DISEASES". Nanocomposix has previously provided lateral flow assay devices, gold nanoparticles, and research and development...
This is a $299,633 Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Giner Inc., a Boston-based research and development firm. The contract is for the development of a "smartphone-integrated point-of-care sensor for rapid and sensitive detection of malaria in low-resource applications." Giner Inc. has experience delivering technology...
This is a $300,000.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Kephera Diagnostics LLC, a small business, for the discovery and validation of novel diagnostic biomarkers for malaria and select neglected tropical diseases. The contract is a Small Business Innovation Research (SBIR) Phase I award, meaning it supports early-stage research and development efforts. The work will be performed in Framingham,...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, has awarded a $300,000 Firm Fixed Price Definitive Contract to L2 Diagnostics LLC, a small business, for the NOVEL DIAGNOSTIC BIOMARKERS DISCOVERY AND VALIDATION FOR MALARIA SBIR PHASE I effort. This Small Business Innovation Research (SBIR) Phase I contract has a performance period ending on November 30, 2025 and is set aside for total small business participation. L2 Diagnostics LLC is a for-profit limited...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, awarded a $224,751 firm-fixed-price contract to Glucosentient Inc., a small business, for the development of a "TELE-MONITORING FOR INFECTIOUS DISEASES: A REMOTE SYSTEM FOR ASSESSING PATIENT PARAMETERS AND SPECIMEN ANALYSIS." The contract, which has an ultimate completion date of August 29, 2017, was set aside for small businesses. Glucosentient, a...